TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $21,741 | -26.2% | 45,294 | -24.7% | 0.00% | – |
| Q1 2023 | $29,459 | +9.9% | 60,120 | 0.0% | 0.00% | – |
| Q4 2022 | $26,814 | -34.6% | 60,120 | 0.0% | 0.00% | – |
| Q3 2022 | $41,000 | -16.3% | 60,120 | 0.0% | 0.00% | – |
| Q2 2022 | $49,000 | +345.5% | 60,120 | +666.9% | 0.00% | – |
| Q1 2022 | $11,000 | -68.6% | 7,839 | -10.7% | 0.00% | – |
| Q4 2021 | $35,000 | -62.8% | 8,781 | -41.5% | 0.00% | – |
| Q3 2021 | $94,000 | +5.6% | 15,007 | +85.9% | 0.00% | – |
| Q2 2021 | $89,000 | -16.8% | 8,072 | -3.2% | 0.00% | – |
| Q1 2021 | $107,000 | – | 8,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|